Manching, Germany: Airbus makes the future fly, Human Tecar on board

21 June, 2016 - Categories: Anti-stress Events

Mario Scerri, our CEO and founder of Human Tecar, visited Airbus Defence and Space in Manching on the occasion of their June Air Show.

He was flanked by the “top guns” of Human Tecar physiotherapy, who assisted Airbus test pilots before and after their heart-stopping performances.

The German Group has once more proven how committed it is to its most precious assets: pilots. If their Eurofighter is the world’s most advanced fighter plane and the brand new cargo aircraft, Beluga, appears to defy the laws of physics, those at the controls of these titanium and steel wonders undergo the same, extreme conditions – with one major disadvantage: they may be almost superhuman, but they’re still made of flesh and bone.

Bravo to Airbus then for their protection of a very rare ‘species,’ worthy of these giants of the sky. We are honored we had the chance to place our team and technology at their service.

Related articles
27 July, 2022

Humantecar thanks Professor Carlo Tranquilli, sports physician and forerunner of the Original Humantecar Tecartherapy.

In sports, when you win it is always because of the athlete or a team made up of athletes. If we are talking about great athletes or great teams, very often, when we lose, the[...]

19 April, 2021

Banca Mediolanum and Unibell, a co-marketing operation dedicated to over a million of people.

Humantecar® and Omeoenergetica® joined the merchandising that Banca Mediolanum reserves to its vast community of customers. A catalogue of Italian excellence in which we introduce our experience in the Healthcare, with some of the references[...]

Medical information

The information provided on our website is supplied as a service to our clients and should not be used in place of advice and recommendations from qualified, registered medical sources. Always seek the opinion of a qualified medical professional if you believe you may be suffering from a medical condition discussed on our site.